Parametric Portfolio Associates’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$611K Sell
24,317
-3,133
-11% -$78.7K ﹤0.01% 3001
2021
Q4
$984K Sell
27,450
-5,762
-17% -$207K ﹤0.01% 2791
2021
Q3
$1.41M Buy
33,212
+335
+1% +$14.3K ﹤0.01% 2636
2021
Q2
$1.42M Buy
32,877
+12,181
+59% +$527K ﹤0.01% 2610
2021
Q1
$844K Buy
20,696
+626
+3% +$25.5K ﹤0.01% 3243
2020
Q4
$908K Sell
20,070
-2,611
-12% -$118K ﹤0.01% 3095
2020
Q3
$803K Buy
22,681
+1,126
+5% +$39.9K ﹤0.01% 3049
2020
Q2
$813K Sell
21,555
-11,550
-35% -$436K ﹤0.01% 3028
2020
Q1
$957K Sell
33,105
-21,225
-39% -$614K ﹤0.01% 2815
2019
Q4
$2.82M Buy
54,330
+3,240
+6% +$168K ﹤0.01% 2460
2019
Q3
$2.8M Buy
51,090
+432
+0.9% +$23.7K ﹤0.01% 2437
2019
Q2
$2.06M Buy
50,658
+38,771
+326% +$1.58M ﹤0.01% 2654
2019
Q1
$359K Sell
11,887
-3,836
-24% -$116K ﹤0.01% 3478
2018
Q4
$528K Sell
15,723
-16,276
-51% -$547K ﹤0.01% 3285
2018
Q3
$1.35M Buy
31,999
+20,555
+180% +$867K ﹤0.01% 2932
2018
Q2
$366K Sell
11,444
-1,269
-10% -$40.6K ﹤0.01% 3473
2018
Q1
$632K Buy
12,713
+1,062
+9% +$52.8K ﹤0.01% 3234
2017
Q4
$628K Buy
11,651
+249
+2% +$13.4K ﹤0.01% 3223
2017
Q3
$661K Buy
11,402
+1,626
+17% +$94.3K ﹤0.01% 3270
2017
Q2
$482K Sell
9,776
-2,440
-20% -$120K ﹤0.01% 3391
2017
Q1
$531K Sell
12,216
-1,541
-11% -$67K ﹤0.01% 3177
2016
Q4
$674K Sell
13,757
-3,002
-18% -$147K ﹤0.01% 3040
2016
Q3
$802K Sell
16,759
-3,712
-18% -$178K ﹤0.01% 2933
2016
Q2
$1.1M Sell
20,471
-66
-0.3% -$3.54K ﹤0.01% 2754
2016
Q1
$918K Sell
20,537
-2,109
-9% -$94.3K ﹤0.01% 2982
2015
Q4
$864K Buy
22,646
+755
+3% +$28.8K ﹤0.01% 2900
2015
Q3
$697K Sell
21,891
-435
-2% -$13.9K ﹤0.01% 2546
2015
Q2
$737K Sell
22,326
-8,386
-27% -$277K ﹤0.01% 3005
2015
Q1
$1.26M Sell
30,712
-9,355
-23% -$385K ﹤0.01% 2613
2014
Q4
$1.63M Sell
40,067
-174
-0.4% -$7.09K ﹤0.01% 2368
2014
Q3
$1.48M Sell
40,241
-97
-0.2% -$3.56K ﹤0.01% 2359
2014
Q2
$1.87M Buy
40,338
+9,221
+30% +$427K ﹤0.01% 2149
2014
Q1
$1.28M Buy
31,117
+19,443
+167% +$799K ﹤0.01% 2456
2013
Q4
$445K Buy
+11,674
New +$445K ﹤0.01% 3240